Secor Capital Advisors’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Secor Capital Advisors’s Portfolio SCMP Stock Details SCMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-46,687	Closed	-$575K	–	695
2016 Q3	$575K	Sell	46,687 -22,001	-32%	-$259K	0.06%	336
2016 Q2	$754K	Buy	+68,688	New	+$769K	0.1%	293
2015 Q2	–	Sell	-17,512	Closed	-$272K	–	607
2015 Q1	$272K	Buy	+17,512	New	+$271K	0.11%	337

Other funds holding SCMP

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Redwood Investments Boston, Massachusetts $267M AUM 11.99% 1-Year Est. Return

Secor Capital Advisors's SCMP Position: Q4 2016 in Review

Secor Capital Advisors sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q4 2016, closing a stake of 46,687 shares — an estimated $575K sold.

Secor Capital Advisors first reported a position in SCMP in Q1 2015 and held it in 3 quarters. The position peaked at $754K in Q2 2016. 165 funds tracked by Wall St. Rank hold SCMP as of Q4 2016.

Secor Capital Advisors reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q4 2016 after selling out during the quarter.
Secor Capital Advisors sold 46,687 Sucampo Pharmaceuticals, Inc. shares in Q4 2016, an estimated $575K.
Secor Capital Advisors first reported a position in Sucampo Pharmaceuticals, Inc. in Q1 2015 and held it in 3 quarters.
Secor Capital Advisors's Sucampo Pharmaceuticals, Inc. position peaked at $754K in Q2 2016.
165 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q4 2016.

Based on Secor Capital Advisors's 13F filing for Q4 2016, filed 14 Feb 2017.